Grow Partners’s Repligen RGEN Stock Holding History

Grow Partners’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-244,000	Closed	-$3.33M	–	33
2013 Q4	$3.33M	Buy	+244,000	New	+$2.91M	2.03%	21

Other funds holding RGEN

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Grow Partners's RGEN Position: Q1 2014 in Review

Grow Partners sold out of Repligen (RGEN) in Q1 2014, closing a stake of 244,000 shares — an estimated $3.33M sold.

Grow Partners first reported a position in RGEN in Q4 2013 and held it in 1 quarter. The position peaked at $3.33M in Q4 2013. 136 funds tracked by Wall St. Rank hold RGEN as of Q1 2014.

Grow Partners reported no remaining Repligen position as of Q1 2014 after selling out during the quarter.
Grow Partners sold 244,000 Repligen shares in Q1 2014, an estimated $3.33M.
Grow Partners first reported a position in Repligen in Q4 2013 and held it in 1 quarter.
Grow Partners's Repligen position peaked at $3.33M in Q4 2013.
136 funds tracked by Wall St. Rank held Repligen as of Q1 2014.

Based on Grow Partners's 13F filing for Q1 2014, filed 13 May 2014.